Literature DB >> 22725693

Fine-tuning multiprotein complexes using small molecules.

Andrea D Thompson1, Amanda Dugan, Jason E Gestwicki, Anna K Mapp.   

Abstract

Multiprotein complexes such as the transcriptional machinery, signaling hubs, and protein folding machines are typically composed of at least one enzyme combined with multiple non-enzymes. Often the components of these complexes are incorporated in a combinatorial manner, in which the ultimate composition of the system helps dictate the type, location, or duration of cellular activities. Although drugs and chemical probes have traditionally targeted the enzyme components, emerging strategies call for controlling the function of protein complexes by modulation of protein-protein interactions (PPIs). However, the challenges of targeting PPIs have been well documented, and the diversity of PPIs makes a "one-size-fits-all" solution highly unlikely. These hurdles are particularly daunting for PPIs that encompass large buried surface areas and those with weak affinities. In this Review, we discuss lessons from natural systems, in which allostery and other mechanisms are used to overcome the challenge of regulating the most difficult PPIs. These systems may provide a blueprint for identifying small molecules that target challenging PPIs and affecting molecular decision-making within multiprotein systems.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22725693      PMCID: PMC3517816          DOI: 10.1021/cb300255p

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  116 in total

1.  Allosteric inhibition of the regulator of G protein signaling-Galpha protein-protein interaction by CCG-4986.

Authors:  David L Roman; Levi L Blazer; C Aaron Monroy; Richard R Neubig
Journal:  Mol Pharmacol       Date:  2010-06-07       Impact factor: 4.436

Review 2.  Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.

Authors:  Michelle R Arkin; James A Wells
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

Review 3.  Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery.

Authors:  Stéphanie Pérot; Olivier Sperandio; Maria A Miteva; Anne-Claude Camproux; Bruno O Villoutreix
Journal:  Drug Discov Today       Date:  2010-06-04       Impact factor: 7.851

Review 4.  Post-translational modifications in signal integration.

Authors:  Yonathan Lissanu Deribe; Tony Pawson; Ivan Dikic
Journal:  Nat Struct Mol Biol       Date:  2010-05-23       Impact factor: 15.369

5.  Uncoupling of bait-protein expression from the prey protein environment adds versatility for cell and tissue interaction proteomics and reveals a complex of CARP-1 and the PKA Cbeta1 subunit.

Authors:  Andrea Erlbruch; Chien-Wen Hung; Joerg Seidler; Katrin Borrmann; Frank Gesellchen; Norbert König; Dieter Kübler; Friedrich W Herberg; Wolf D Lehmann; Dirk Bossemeyer
Journal:  Proteomics       Date:  2010-08       Impact factor: 3.984

Review 6.  Covalent modifiers: an orthogonal approach to drug design.

Authors:  Michele H Potashman; Mark E Duggan
Journal:  J Med Chem       Date:  2009-03-12       Impact factor: 7.446

7.  Binding of a small molecule at a protein-protein interface regulates the chaperone activity of hsp70-hsp40.

Authors:  Susanne Wisén; Eric B Bertelsen; Andrea D Thompson; Srikanth Patury; Peter Ung; Lyra Chang; Christopher G Evans; Gladis M Walter; Peter Wipf; Heather A Carlson; Jeffrey L Brodsky; Erik R P Zuiderweg; Jason E Gestwicki
Journal:  ACS Chem Biol       Date:  2010-06-18       Impact factor: 5.100

8.  Discovery of PDK1 kinase inhibitors with a novel mechanism of action by ultrahigh throughput screening.

Authors:  Ekaterina V Bobkova; Michael J Weber; Zangwei Xu; Yan-Ling Zhang; Joon Jung; Peter Blume-Jensen; Alan Northrup; Priya Kunapuli; Jannik N Andersen; Ilona Kariv
Journal:  J Biol Chem       Date:  2010-04-12       Impact factor: 5.157

9.  Reversible, allosteric small-molecule inhibitors of regulator of G protein signaling proteins.

Authors:  Levi L Blazer; David L Roman; Alfred Chung; Martha J Larsen; Benjamin M Greedy; Stephen M Husbands; Richard R Neubig
Journal:  Mol Pharmacol       Date:  2010-06-22       Impact factor: 4.436

Review 10.  Bifunctional recombinant proteins in cancer therapy: cell penetrating peptide aptamers as inhibitors of growth factor signaling.

Authors:  Claudia Buerger; Bernd Groner
Journal:  J Cancer Res Clin Oncol       Date:  2003-09-11       Impact factor: 4.553

View more
  53 in total

1.  Chemical Perturbation of Oncogenic Protein Folding: from the Prediction of Locally Unstable Structures to the Design of Disruptors of Hsp90-Client Interactions.

Authors:  Antonella Paladino; Mark R Woodford; Sarah J Backe; Rebecca A Sager; Priyanka Kancherla; Michael A Daneshvar; Victor Z Chen; Dimitra Bourboulia; Elham F Ahanin; Chrisostomos Prodromou; Greta Bergamaschi; Alessandro Strada; Marina Cretich; Alessandro Gori; Marina Veronesi; Tiziano Bandiera; Renzo Vanna; Gennady Bratslavsky; Stefano A Serapian; Mehdi Mollapour; Giorgio Colombo
Journal:  Chemistry       Date:  2020-07-08       Impact factor: 5.236

Review 2.  The Chemical Biology of Molecular Chaperones--Implications for Modulation of Proteostasis.

Authors:  Kristoffer R Brandvold; Richard I Morimoto
Journal:  J Mol Biol       Date:  2015-05-21       Impact factor: 5.469

3.  Small-molecule CaVα1⋅CaVβ antagonist suppresses neuronal voltage-gated calcium-channel trafficking.

Authors:  Xingjuan Chen; Degang Liu; Donghui Zhou; Yubing Si; David Xu; Christopher W Stamatkin; Mona K Ghozayel; Matthew S Ripsch; Alexander G Obukhov; Fletcher A White; Samy O Meroueh
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-24       Impact factor: 11.205

Review 4.  Inhibitors and chemical probes for molecular chaperone networks.

Authors:  Jason E Gestwicki; Hao Shao
Journal:  J Biol Chem       Date:  2018-09-13       Impact factor: 5.157

5.  Validation of the Hsp70-Bag3 protein-protein interaction as a potential therapeutic target in cancer.

Authors:  Xiaokai Li; Teresa Colvin; Jennifer N Rauch; Diego Acosta-Alvear; Martin Kampmann; Bryan Dunyak; Byron Hann; Blake T Aftab; Megan Murnane; Min Cho; Peter Walter; Jonathan S Weissman; Michael Y Sherman; Jason E Gestwicki
Journal:  Mol Cancer Ther       Date:  2015-01-06       Impact factor: 6.261

6.  Dissecting allosteric effects of activator-coactivator complexes using a covalent small molecule ligand.

Authors:  Ningkun Wang; Jean M Lodge; Carol A Fierke; Anna K Mapp
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

7.  Ordering a dynamic protein via a small-molecule stabilizer.

Authors:  Ningkun Wang; Chinmay Y Majmudar; William C Pomerantz; Jessica K Gagnon; Jack D Sadowsky; Jennifer L Meagher; Taylor K Johnson; Jeanne A Stuckey; Charles L Brooks; James A Wells; Anna K Mapp
Journal:  J Am Chem Soc       Date:  2013-02-22       Impact factor: 15.419

Review 8.  Expanding the number of 'druggable' targets: non-enzymes and protein-protein interactions.

Authors:  Leah N Makley; Jason E Gestwicki
Journal:  Chem Biol Drug Des       Date:  2013-01       Impact factor: 2.817

Review 9.  Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area.

Authors:  Xu Ran; Jason E Gestwicki
Journal:  Curr Opin Chem Biol       Date:  2018-06-13       Impact factor: 8.822

10.  Targeting transcription is no longer a quixotic quest.

Authors:  Anna K Mapp; Rachel Pricer; Steven Sturlis
Journal:  Nat Chem Biol       Date:  2015-12       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.